< Back to companies
Genopsy (제놉시)

Genopsy (제놉시)

Seoul, South Korea

Genopsy diagnoses cancer based on body fluids such as saliva, sputum, and blood. Genopsy's proprietary nanowire-based assay offers a direct, simple alternative to the conventional methods used to detect blood and non-blood circulating tumor DNAs, enabling early diagnosis of cancer and diagnosis of recurrence after treatment.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2017
Website
genopsy-biotech.com

Categories

CancerDiagnostics

Disease Areas

Technologies

Liquid BiopsyGenetic AnalysisMolecular DiagnosticsGenomics
Only accessible to MedStartr community members. Join now

What do you think of Genopsy (제놉시)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now